|
| |
Biota Holdings Limited Australia Pages on BioPortfolio:
BioPortfolio - Biota Holdings Limited Australia - Profile
BioNews Results for Biota Holdings Limited Australia. • Biota Holdings Limited ( ASX:BTA) Relenza Q1 Royalty Of $1.9M On Sales of $27.1M ...
http://www.bioportfolio.com/biocorporate/1891-Biota+Holdings...
|
BioPortfolio - Biota Holdings Limited Australia
Biota Holdings Limited Australia - Entry on Bioportfolio's Biocorporate Database .
http://www.bioportfolio.com/biocorporate/1891-Biota_Holdings...
|
BioPortfolio - Biota Holdings Limited Australia - Profile
BioNews Results for Biota Holdings Limited Australia. • Examine the Asia Pacific Biotechnology Market (2008-2012). Street Insider: Sep 18 2008 11:32AM ...
http://www.bioportfolio.com/biocorporate/1891-Biota%2BHoldin...
|
Daiichi Sankyo & Biota start Phase III Asian trials for next ...
Biota Holdings Limited (ASX:BTA) Melbourne, Australia – 17 November 2008 - today announced that the multiple centres involved in the Phase III clinical ...
http://www.bioportfolio.com/biotech_news/BIOTA_11.htm...
|
LANI completes Phase I in Japan and to commence Phase I in UK
19 Apr 2007 ... In Europe and the US, Australia-based Biota Holdings Ltd., a joint development company, is conducting Phase I trials for CS-8958. ...
http://www.bioportfolio.com/biotech_news/BIOTA_1.htm...
|
Biota (ASX:BTA) receives $1.9million Relenza royalties from GSK ...
Melbourne, Australia, 23 October 2008… Biota Holdings Limited (ASX:BTA) today announced that it had received written notification from GlaxoSmithKline (GSK)
...
http://www.bioportfolio.com/biotech_news/BIOTA_10.htm...
|
Biota (ASX:BTA) announces LANI Phase II trial commencement
Melbourne, Australia — 22 November 2007: Biota Holdings Limited (ASX:BTA) today announced that its long acting neuraminidase inhibitor (LANI), CS8958, ...
http://www.bioportfolio.com/biotech_news/BIOTA_4.htm...
|
Biota (ASX:BTA) F2008 Annual Results
Melbourne, Australia — 26 August 2008, Biota Holdings Limited (ASX:BTA) today announced a full year loss after tax of $6.5 million (2007: profit $20.2m). ...
http://www.bioportfolio.com/biotech_news/BIOTA_9.htm...
|
BioPortfolio - Managing Director Boehringer Australia
Melbourne, Australia — 26 August 2008, Biota Holdings Limited (ASX:BTA) today announced a full ... agreements with MedImmune Inc. and Boehringer Ingelheim.
...
http://www.bioportfolio.com/search/Managing_Director__Boehri...
|
Former SmithKline Beecham chairman Martin Greenacre to speak at ...
4 Oct 2006 ... Australian nanobiotech company Starpharma Holdings Limited today announced the signing of an agreement to acquire US-based Dendritic ...
http://www.bioportfolio.com/biotech_news/Intersuisse_Bioscie...
|
Results from other life science and pharmaceutical sites:
Biota Holdings Limited: Board of Directors & Senior Management
Since returning to Australia, she has worked with Peptech before joining Biota Holdings Ltd where she has had roles in managing commercialisation of ...
http://www.biota.com.au/?page=1021000&subpage=1021167...
|
BioSpace - Biota Holdings Limited News, Search Jobs, Events
Biota Holdings Limited Level 4, 616 St. Kilda Road Melbourne Victoria 3004 Australia Phone: 61-3-9529-2311 Fax: 61-3-9529-2261 ...
http://www.biospace.com/company_profile.aspx?CompanyID=1860...
|
Biota Holdings Limited: Scientific Publications & Presentations
Careers Teacher Symposium at Monash University, Melbourne, Australia. August 2006 ... Copyright 2006 Biota Holdings Limited. All rights reserved.
http://www.biota.com.au/?page=1021003&subpage=1021025...
|
BioPortfolio - Biota Holdings Limited Australia - Profile
BioNews Results for Biota Holdings Limited Australia. • Biota Holdings Limited ( ASX:BTA) Relenza Q1 Royalty Of $1.9M On Sales of $27.1M ...
http://www.bioportfolio.com/biocorporate/1891-Biota+Holdings...
|
For Immediate Release Melbourne, Australia — 31 July 2008 LANI ...
31 Jul 2008 ... Melbourne, Australia — 31 July 2008. LANI Phase II completed - Phase III scheduled. Biota Holdings Limited (ASX:BTA) today announced that ...
http://www.biota.com.au/uploaded/154/1021393_18laniphaseiico...
|
Biota Holdings Limited RSV License Assigned to AstraZeneca PLC And ...
Melbourne, Australia, Aug 25, 2008 - (ABN Newswire) - Biota Holdings Limited ( ASX:BTA) and AstraZeneca (LON:AZN)(NYSE:AZN) today announced that the 2005 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107711...
|
For Immediate Release Melbourne, Australia – 17 November 2008 LANI ...
17 Nov 2008 ... Melbourne, Australia – 17 November 2008. LANI Phase III clinical trials set for enrolment. Biota Holdings Limited (ASX:BTA) today announced ...
http://www.biota.com.au/uploaded/154/1021460_34lanistartofph...
|
Biota Holdings Limited and MedImmune, Inc. RSV Drug Starts Phase ...
MELBOURNE, Australia and GAITHERSBURG, Md., July 16 /PRNewswire/-- Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia ...
http://www.biospace.com/news_story.aspx?NewsEntityId=63144...
|
For Immediate Release Melbourne, Australia — 19 April 2007 LANI ...
Melbourne, Australia — 19 April 2007. LANI completes Phase I in Japan and to commence Phase I in UK. Biota Holdings Limited (ASX:BTA) today announced that
...
http://www.biota.com.au/uploaded/154/1021259_63laniphaseicom...
|
Biota Holdings Limited Says New Evidence Details GlaxoSmithKline's ...
Biota Holdings Limited. CONTACT: Australia: Tim Duncan or Nerida Mossop, both of Hinton &Associates, +61-3-9600-1979, or mobile, +61-408-441-122; ...
http://www.biospace.com/news_story.aspx?NewsEntityId=50734...
|
|
